November 2, 2021 at 10:00 AM ET (sign up here)

Please join us to review recent and upcoming clinical and regulatory developments in skin and auto-immune disease. Bloomberg Intelligence analyst Michael Shah, and Senior Principal of inThought Research Amanda Weyerbacher, PhD, will be joined by dermatologist Steven R. Feldman, MD, PhD and rheumatologist Christopher Ritchlin MD, MPH, for a discussion around prescribing trends, the competitive landscape and key mechanisms and drugs of interest, including the JAK class, Bimzelx, Dupixent and lebrikizumab.

Read more

June 9 at 11am – 12:30pm ET (sign up here)

Please join us for a review of key data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. Bloomberg Intelligence analysts Marc Engelsgjerd, MD, and Sam Fazeli, PhD, and inThought Research analyst Matt Presby, PhD, will be joined by expert speakers Patrick Forde, MBBCh, and Ravi Vij, MD, for a discussion of ASCO presentations of interest, including emerging data from checkpoint inhibitors, cell therapies, and targeted small molecules.

Read more

September 18, 2020 at 11:00 AM EST

Bloomberg Intelligence and inThought host a call with Spinal Muscular Atrophy experts for an in-depth review of the spinal muscular atrophy (SMA) treatment landscape, which now includes approved drugs from Biogen, Novartis and Roche.

Read more

April 20, 2020 at 11:00 AM EST

Bloomberg Intelligence and inThought will host a call with immunology experts Thurs., Apr 20th at 11AM EST to discuss development of a Covid-19 therapy and how best to interpret clinical data once they begin to emerge.

Read more

April 2, 2020 at 11:00 AM EST / 4:00 PM BST

Please join Bloomberg Intelligence healthcare analysts and inThought Research for a discussion with two vaccine experts, who will share their views on the prospects for developing a vaccine against the novel coronavirus. We will discuss specific programs as well as general considerations for mRNA and other vaccine development.

Read more